The Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Artificial Intelligence (AI) In Respiratory Diseases Market:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report
According to The Business Research Company’s Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2024, The AI in respiratory diseases market size is expected to see steady growth in the next few years. It will grow to $9.35 billion in 2028 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising need for early detection and diagnosis, growing environmental pollution, rising healthcare expenditure, research and development initiatives. Major trends in the forecast period include technological advancements, drug discovery and development, personalized treatment plans, telemedicine and remote patient monitoring, remote patient monitoring.
Growing environmental pollution is expected to propel the growth of artificial intelligence (AI) in the respiratory disease market going forward. Environmental pollution refers to the addition of any substance or form of energy to the environment at a rate faster than it can be dispersed or stored in a harmless form. AI in respiratory diseases has the potential to significantly reduce the impact of environmental pollution on respiratory health by offering real-time monitoring, personalized risk assessments, informed decision-making, and innovative solutions for both individuals and communities. For instance, in November 2023, according to the United States Environmental Protection Agency, a US-based government agency, in the US around 66 million tons of pollution was emitted into the atmosphere in 2022. Further, US greenhouse gas emissions by the economic sector increased by 6,025.97 million metric tons (MMT) of CO2 in 2020 to 6,340.23 million metric tons (MMT) of CO2 in 2021. Therefore, growing environmental pollution is driving the growth of artificial intelligence (AI) in the respiratory disease market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp
The artificial intelligence (ai) in respiratory diseases market covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Major companies operating in artificial intelligence (AI) in the respiratory diseases market are developing innovative products such as N-Tidal devices to monitor patients’ tidal breathing. The n-Tidal device measures the volume of air exchanged during normal breathing and provides valuable information about lung function. For instance, in August 2023, TidalSense, a UK-based respiratory technology company, launched N-Tidal, a regulated AI technology for chronic obstructive pulmonary disease (COPD) diagnosis and management. The technology combines N-Tidal’s CO2 sensor data with an artificial intelligence platform to measure changes in lung function, aiming to improve the diagnosis and management of this respiratory condition. Clinical studies have demonstrated the technology’s high accuracy, and it is expected to reform the diagnostic process for respiratory diseases. The launch is a significant development in the use of AI for respiratory disease assessment, offering a more comfortable and efficient alternative to existing diagnostic tests.
The artificial intelligence (ai) in respiratory diseases market report table of contents includes:
- Executive Summary
- Artificial Intelligence (AI) In Respiratory Diseases Market Characteristics
- Artificial Intelligence (AI) In Respiratory Diseases Market Trends And Strategies
- Artificial Intelligence (AI) In Respiratory Diseases Market – Macro Economic Scenario
- Global Artificial Intelligence (AI) In Respiratory Diseases Market Size and Growth
.
.
.
- Global Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Benchmarking
- Global Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Dashboard
- Key Mergers And Acquisitions In Artificial Intelligence (AI) In Respiratory Diseases Market
- Artificial Intelligence (AI) In Respiratory Diseases Market Future Outlook and Potential Analysis
- Appendix
Top Major Players :
- Siemens Healthineers
- Philips Healthcare
- General Electric (GE) Healthcare
- Verily Life Sciences LLC
- DeepMind Health
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
